FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3094138049> ?p ?o ?g. }

• W3094138049 endingPage "e42" @default.
• W3094138049 startingPage "e42" @default.
• W3094138049 abstract "Extracellular volume (ECV) fraction, a cardiac MRI (CMR) marker of myocardial tissue remodeling and fibrosis, is analyzed in this proof of concept study to detect myocardial fibrosis in patients with previous thoracic radiotherapy. Twenty-eight patients with no cardiac history and chest tumors treated with radiotherapy, with a heart dose V5Gy ≥ 10%, underwent CMRs (1.5T, Siemens Aera, Erlangen, Germany) on a cross sectional study protocol. Estimation of the ECV (extracellular matrix) required measurement of T1 mapping values before and after administration of gadolinium-based contrast agents, in addition to the patients’ hematocrit value at the time of scan. Cardiac dosimetric variables were gathered from cumulative dose-volume histograms of delivered radiotherapy plans. Mann-Whitney-U tests were performed between ECV fractions and various clinical variables. Spearman’s correlation coefficients were calculated between dosimetric variables and ECV fractions at the left ventricle (LV) base, mid, and apex. Mean time from radiotherapy to CMR was 46.4 months (range 1.7-344.5). Mean V5Gy heart volume was 43.1% (range 10-97%). The cohort consisted of 14 (50%) patients with lung, 9 (32%) with breast, and 5 (18%) with other primary tumors. The median ECV at LV base, mid, and apex was 28% (25-30%), 27% (25-29%), and 30% (27-32%), respectively. Abnormal LV ECV fractions above reported reference range (25.3 ± 3.5%)1 included 8 patients (28.6%) at base, 8 (28.6%) at mid, and 15 (53.6%) at apex. Eighteen patients (64.2%) demonstrated at least 1 abnormal ECV value. There were trends/significant correlations between cardiac LV doses (V10Gy/V20Gy/V30Gy/V40Gy) and ECV fractions at mid LV (p = 0.095, 0.045, 0.043, 0.035, respectively) and at base (p = 0.14, 0.12, 0.043, 0.083, respectively). There were also trends/significant correlations between cardiac LV max dose/mean dose and ECV fractions: at mid ventricle (p = 0.016 and 0.07) and at base (p = 0.068 and 0.072). There were no dosimetric correlations to LV apex ECV fraction. Smoking history as measured in pack years was also correlated with higher ECV fraction at the LV base/mid/apex (p = 0.13/0.03/0.04), consistent with prior literature. There was no significant difference between ECV fractions and other clinical factors, such as chemotherapy use or hypertension diagnosis. Approximately ∼65% of thoracic radiotherapy patients have abnormal ECV fraction values, but this is confounded by preexisting clinical factors such as smoking. There were correlations between higher LV dose and greater ECV fraction size at the LV base and mid LV. This may represent imaging measurement of radiation-induced myocardial fibrosis. Further prospective study is needed to validate this finding." @default.
• W3094138049 created "2020-10-29" @default.
• W3094138049 creator A5015367003 @default.
• W3094138049 creator A5036031874 @default.
• W3094138049 creator A5038893902 @default.
• W3094138049 creator A5049273996 @default.
• W3094138049 creator A5055224715 @default.
• W3094138049 creator A5066539533 @default.
• W3094138049 creator A5069522183 @default.
• W3094138049 creator A5073354256 @default.
• W3094138049 date "2020-11-01" @default.
• W3094138049 modified "2023-09-27" @default.
• W3094138049 title "Extracellular Volume Fraction of Cardiac MRI in the Detection of Cardiac Toxicity from Radiotherapy" @default.
• W3094138049 doi "https://doi.org/10.1016/j.ijrobp.2020.07.1079" @default.
• W3094138049 hasPublicationYear "2020" @default.
• W3094138049 type Work @default.
• W3094138049 sameAs 3094138049 @default.
• W3094138049 citedByCount "0" @default.
• W3094138049 crossrefType "journal-article" @default.
• W3094138049 hasAuthorship W3094138049A5015367003 @default.
• W3094138049 hasAuthorship W3094138049A5036031874 @default.
• W3094138049 hasAuthorship W3094138049A5038893902 @default.
• W3094138049 hasAuthorship W3094138049A5049273996 @default.
• W3094138049 hasAuthorship W3094138049A5055224715 @default.
• W3094138049 hasAuthorship W3094138049A5066539533 @default.
• W3094138049 hasAuthorship W3094138049A5069522183 @default.
• W3094138049 hasAuthorship W3094138049A5073354256 @default.
• W3094138049 hasConcept C126322002 @default.
• W3094138049 hasConcept C126838900 @default.
• W3094138049 hasConcept C143409427 @default.
• W3094138049 hasConcept C151032500 @default.
• W3094138049 hasConcept C164705383 @default.
• W3094138049 hasConcept C2113261 @default.
• W3094138049 hasConcept C2778198053 @default.
• W3094138049 hasConcept C2778921608 @default.
• W3094138049 hasConcept C2780559512 @default.
• W3094138049 hasConcept C28406088 @default.
• W3094138049 hasConcept C2989005 @default.
• W3094138049 hasConcept C3018763269 @default.
• W3094138049 hasConcept C509974204 @default.
• W3094138049 hasConcept C71924100 @default.
• W3094138049 hasConcept C78085059 @default.
• W3094138049 hasConcept C86803240 @default.
• W3094138049 hasConcept C95444343 @default.
• W3094138049 hasConceptScore W3094138049C126322002 @default.
• W3094138049 hasConceptScore W3094138049C126838900 @default.
• W3094138049 hasConceptScore W3094138049C143409427 @default.
• W3094138049 hasConceptScore W3094138049C151032500 @default.
• W3094138049 hasConceptScore W3094138049C164705383 @default.
• W3094138049 hasConceptScore W3094138049C2113261 @default.
• W3094138049 hasConceptScore W3094138049C2778198053 @default.
• W3094138049 hasConceptScore W3094138049C2778921608 @default.
• W3094138049 hasConceptScore W3094138049C2780559512 @default.
• W3094138049 hasConceptScore W3094138049C28406088 @default.
• W3094138049 hasConceptScore W3094138049C2989005 @default.
• W3094138049 hasConceptScore W3094138049C3018763269 @default.
• W3094138049 hasConceptScore W3094138049C509974204 @default.
• W3094138049 hasConceptScore W3094138049C71924100 @default.
• W3094138049 hasConceptScore W3094138049C78085059 @default.
• W3094138049 hasConceptScore W3094138049C86803240 @default.
• W3094138049 hasConceptScore W3094138049C95444343 @default.
• W3094138049 hasIssue "3" @default.
• W3094138049 hasLocation W30941380491 @default.
• W3094138049 hasOpenAccess W3094138049 @default.
• W3094138049 hasPrimaryLocation W30941380491 @default.
• W3094138049 hasRelatedWork W2033207011 @default.
• W3094138049 hasRelatedWork W2367098177 @default.
• W3094138049 hasRelatedWork W2381206123 @default.
• W3094138049 hasRelatedWork W2388618798 @default.
• W3094138049 hasRelatedWork W2398056814 @default.
• W3094138049 hasRelatedWork W2418353436 @default.
• W3094138049 hasRelatedWork W2912421895 @default.
• W3094138049 hasRelatedWork W3024888626 @default.
• W3094138049 hasRelatedWork W3216701433 @default.
• W3094138049 hasRelatedWork W2162704356 @default.
• W3094138049 hasVolume "108" @default.
• W3094138049 isParatext "false" @default.
• W3094138049 isRetracted "false" @default.
• W3094138049 magId "3094138049" @default.
• W3094138049 workType "article" @default.